Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 1999, p. 615-619, Vol. 37, No. 3
Laboratory of Medical Microbiology,
Received 15 April 1998/Returned for modification 23 June
1998/Accepted 3 December 1998
DNA purified from clinical cerebrospinal fluid and urine specimens
by a silica-guanidiniumthiocyanate procedure frequently contained an
inhibitor(s) of DNA-processing enzymes which may have been introduced
by the purification procedure itself. Inhibition could be relieved by
the use of a novel lysis buffer containing alpha-casein. When the novel
lysis buffer was used, alpha-casein was bound by the silica particles
in the first step of the procedure and eluted together with DNA in the
last step, after which it exerted its beneficial effects for
DNA-processing enzymes. In the present study we have compared the novel
lysis buffer with the previously described lysis buffer with respect to
double-stranded DNA yield (which was nearly 100%) and the performance
of DNA-processing enzymes.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Improved Silica-Guanidiniumthiocyanate DNA
Isolation Procedure Based on Selective Binding of Bovine
Alpha-Casein to Silica Particles
*
Corresponding author. Mailing address: Laboratory of
Medical Microbiology, Department of Virology, Section of Clinical
Virology, Meibergdreef 9, 1100 DD Amsterdam, The Netherlands. Phone:
(31-20)-5665472. Fax: (31-20)-6974005.
Journal of Clinical Microbiology, March 1999, p. 615-619, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|